Other News

Madrigal Pharmaceuticals Announces Pricing of Secondary Offering

WEST CONSHOHOCKEN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, today announced the pricing of the previously-announced underwritten secondary offering by […]

CathWorks FFRangio™ System Receives Regulatory Approval in Japan

KFAR-SABA, Israel and ALISO VIEJO, Calif., Dec. 11, 2019 /PRNewswire/ — CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images […]

Merit Medical launches PreludeSYNC EVO™ radial compression device in EMEA

Maastricht, The Netherlands – 11th December 2019 Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in cardiology, radiology, oncology, and endoscopy, announces the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets. The product has FDA clearance in the […]

ELDORADO Selects AdaCore’s QGen for Critical Medical Applications

Model-based engineering toolsuite brings high reliability to medical device software NEW YORK & PARIS & CAMPINAS, Brazil–(BUSINESS WIRE)–AdaCore today announced that The ELDORADO Research Institute of Brazil (ELDORADO) has selected the QGen model-based code generation and verification toolsuite to support research and development of safety-critical medical device software. These applications […]

CORRECTING and REPLACING First Patient Enrolled in PROMISE II U.S. Pivotal Study of LimFlow System to Treat Chronic Limb-threatening Ischemia

Clinical Study to Evaluate Device’s Ability to Prevent Amputation and Promote Wound Healing in Patients with No Other Options CORRECTION…by LimFlow SA PARIS–(BUSINESS WIRE)–First paragraph, last sentence should read: The successful first case was performed by Mark Archie, MD, principal investigator for the PROMISE II trial at Harbor-UCLA Medical Center, […]

InspireMD Announces Planned Leadership Transition

Life sciences industry veteran Marvin Slosman appointed Chief Executive Officer   Appointment adds significant medical technology commercialization experience to the InspireMD team TEL AVIV, Israel, Dec. 10, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused […]